Thomas Nusbickel - 13 May 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
EVP, Chief Commercial Officer
Signature
/s/ Thomas Nusbickel
Issuer symbol
CRMD
Transactions as of
13 May 2021
Net transactions value
$0
Form type
4
Filing time
20 May 2021, 16:18:37 UTC
Next filing
23 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +260,000 $0.000000 260,000 13 May 2021 Common Stock 260,000 $7.56 Direct F1
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +7,500 $0.000000 7,500 13 May 2021 Common Stock 7,500 $7.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment.
F2 These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment.